SPRY ARS Corp: Long-Term Debt to Capital Coefficient

Symbol and logo of brand ARS Corp (SPRY)

ARS Pharmaceuticals (SPRY) specializes in creating needle-free drug delivery methods, developing a unique nasal product to combat anaphylactic shock. This daily price action for the company's shares on GURU.Markets currently stands at 7.19. However, business development is complicated by global political tensions, which disrupt raw material logistics and slow down the international approval of new medicinal products.

SPRY - ARS Pharmaceuticals Inc Long-Term Debt to Equity over the range 04/28/2023 - 10/29/2026

Comprehensive metric breakdowns and analytics for ARS Pharmaceuticals (SPRY)

- price and consensus price forecast:
Quote Chart ARS Pharmaceuticals Inc|SPRY - Analyst Consensus Forecast
- market capitalization data:
Market Value ARS Pharmaceuticals, Inc.|SPRY - Enterprise Value
- book capitalization data:
Book Value per Share ARS Pharmaceuticals|SPRY - Company Book Value|Market Value to Book Value ars-pharma.com|SPRY - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio ARS Pharmaceuticals|SPRY - Long-Term Debt to Capital|Short-Term Debt to Capital ars-pharma.com|SPRY - Company Total Debt|Debt to Net Assets Ratio ARS Pharmaceuticals, Inc.|SPRY - Company Long-Term Debt|Short-Term Debt ARS Pharmaceuticals
Initial company analysis:ARS Pharmaceuticals Inc
Core merchandise of ARS Pharmaceuticals

To assess the long-term financial stability of ARS Pharmaceuticals (SPRY), it is critical to analyze the ratio of liabilities with a maturity of over one year to equity. This ratio of long-term debt to equity determines the degree of leverage, where a low figure minimizes default risks during the technical re-equipment of bottling lines and the expansion of nasal spray production capacities.

Who ARS Pharmaceuticals competes with

Long-Term Liabilities to Equity Haleon PLC|Kenvue Corp (KVUE) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Verona Pharma Inc. (VRNA)|Long-Term Debt to Capital MENS (Jyong Biotech Ltd)|ligand.com - Long-Term Debt to Capital|Long-Term Debt to Equity Amneal (AMRX)|PRGO: Long-Term Debt to Capital Coefficient|ALVO (Alvotech Corp) - Long-Term Debt to Equity|Liquidia Inc. (LQDA) - Long-Term Debt to Equity Ratio|GLPG (Galapagos NV) - Long-Term Debt to Capital|Long-Term Debt to Capital anipharmaceuticals.com (ANIP)|MannKind (MNKD) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient AMPH (Amphastar Pharmaceuticals Inc)|PCRX: Long-Term Debt to Equity|TBPH - Long-Term Liabilities to Capital|Long-Term Debt to Equity Ratio Aquestive Therapeutics AQST|SCPH - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital tectonictx.com TECX|Tonix Pharma (TNXP) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital SXTC (SXT Pharmaceuticals)|Long-Term Liabilities to Capital EPRX|BioHarvest Sciences (BHST) - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient invizyne.com (EXOZ)|Long-Term Debt to Capital ORMP (Oramed Pharmaceuticals Inc.)|Entera Bio Ltd - Long-Term Debt to Capital|Long-Term Debt to Equity MindWalk (HYFT)|ABVC: Long-Term Debt to Capital Coefficient|Cumberland Pharmaceuticals - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital quantumbiopharma.com|FGEN - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TELO|RANI - Long-Term Debt to Equity|Long-Term Liabilities to Equity synergychc.com (SNYR)|Long-Term Debt to Capital Rallybio|Long-Term Debt to Capital Coefficient Lexaria Bioscience Corp LEXX|Pulmatrix - Long-Term Debt to Capital|PTHL: Long-Term Debt to Capital|Long-Term Debt to Equity aptorumgroup.com APM|LYRA (Lyra Therapeutics Inc) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IBO|Long-Term Debt to Equity Ratio TNF Pharma|Long-Term Debt to Capital YCBD|Long-Term Debt to Capital PainReform Ltd (PRFX)|Altamira Therapeutics Ltd. - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Lipella Pharma LIPO|OPTN (OptiNose, Inc.) - Long-Term Debt to Capital|pieris.com (PIRS) - Long-Term Liabilities to Capital|PROC: Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Petros Pharmaceuticals Inc|Qilian International Holding Group Limited (QLI) - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio ACELYRIN Inc.|TFFP (TFF Pharmaceuticals) - Long-Term Debt to Capital